Related Experiment Video
Updated: Jul 16, 2025

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.6K
Patient-reported outcomes in clinical HIV care: protocol for a single-centre, multistage, mixed-methods study in
Olivia Borchmann1, Nina Weis2,3, Ann-Brit Eg Hansen2,3
1Department of Infectious Diseases, Hvidovre Hospital, Copenhagen University Hospital, Hvidovre, Denmark oliviaborchmann@gmail.com.
BMJ Open
|September 14, 2023
Summary
Patient-reported outcomes (PROs) can improve health-related quality of life (HRQoL) for people with HIV-1 (PWH). This study developed and evaluated PROs in HIV care, aiming to enhance patient outcomes and healthcare provider awareness.
Area of Science:
- HIV/AIDS Research
- Patient-Reported Outcomes (PROs)
- Health Services Research
Background:
- People with HIV-1 (PWH) experience diminished health-related quality of life (HRQoL).
- Patient-reported outcomes (PROs) offer a means to improve focus on HRQoL in HIV care.
- Developing and implementing PROs is crucial for enhancing patient-centered HIV management.
Purpose of the Study:
- To develop, implement, and evaluate the use of PROs in HIV care.
- To identify relevant PRO domains and assess barriers/benefits of PRO use.
- To evaluate the impact of PRO use on healthcare provider (HCP) awareness and documentation.
Main Methods:
- A mixed-methods study involving qualitative (focus groups, interviews) and quantitative (surveys, before-and-after analysis) substudies.
- Development of a patient-reported outcome measure (PROM) based on qualitative findings.
- Assessment of PWH willingness to engage with PROs and HCP awareness of PRO results.
Main Results:
- Qualitative data informed the design of a PROM.
- Quantitative data assessed PWH engagement with PROMs.
- Analysis compared HCP documentation rates before and after PRO implementation.
Conclusions:
- PROs hold potential for reorienting HIV care towards improving HRQoL.
- The study provides insights into the development and implementation of PROs in HIV settings.
- Further research can build upon these findings to optimize PRO integration in clinical practice.
Related Concept Videos
Study Designs in Epidemiology
263
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
263
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K

